The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.

about

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.

Item

http://www.wikidata.org/entity/Q47150055

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@en

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@nl

type

Item

label

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@en

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@nl

prefLabel

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@en

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@nl

P1476

The EZH2 inhibitor GSK343 supp ...... al transition in glioma cells.

@en

P2093

Dongfeng Han

http://www.w3.org/2001/XMLSchema#string

Ning Lin

http://www.w3.org/2001/XMLSchema#string

Ning Liu

http://www.w3.org/2001/XMLSchema#string

Qi Hu

http://www.w3.org/2001/XMLSchema#string

Tianfu Yu

http://www.w3.org/2001/XMLSchema#string

WeiNing Wu

http://www.w3.org/2001/XMLSchema#string

Wenjin Wei

http://www.w3.org/2001/XMLSchema#string

Yingyi Wang

http://www.w3.org/2001/XMLSchema#string

Yongping You

http://www.w3.org/2001/XMLSchema#string

Youzhi Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

The Polycomb group protein EZH2 directly controls DNA methylation

EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

The polycomb group protein EZH2 is involved in progression of prostate cancer

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation.

Aberrations of EZH2 in cancer.

P304

98348-98359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21311

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228694

http://www.w3.org/2001/XMLSchema#string

P932

5716734

http://www.w3.org/2001/XMLSchema#string